News | June 01, 2026
Indoco's formulation plant at Baddi receives EU GMP certification
This certification confirms that the facility complies with Good Manufacturing Practice requirements as referred in the EC Directive
This certification confirms that the facility complies with Good Manufacturing Practice requirements as referred in the EC Directive
The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
Brivaracetam Oral Solution (10 mg/mL) is a prescription antiepileptic drug (anticonvulsant) used for treatment of partial-onset seizures in patients 1 month of age and older
Rivaroxaban is used to treat venous thromboembolism
This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies
Allopurinol is used to prevent or lower high uric acid levels in the blood
Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
The EU certification will support supplies of drug products registered in Europe, from this manufacturing site
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
